Francesco Nicassio
- Molecular Biology top 5%
- Cancer Research top 1%
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Genetics
- Co-authors
- Pier Paolo Di FioreMatteo Jacopo MarziFabrizio BianchiElisabetta CitterioPatrick MaisonneuveGiulia VeronesiFrancesco GhiniJoseph H.A. Vissers
- Topics
- MicroRNA in disease regulation (21 papers)Cancer-related molecular mechanisms research (19 papers)RNA modifications and cancer (12 papers)
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Francesco Nicassio
46 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 102
- Molecular Biology 1.9k
- Cancer Research 1.1k
- Oncology 305
- Pulmonary and Respiratory Medicine 244
- Genetics 133
Countries citing papers authored by Francesco Nicassio
This map shows the geographic impact of Francesco Nicassio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Nicassio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Nicassio more than expected).
Fields of papers citing papers by Francesco Nicassio
This network shows the impact of papers produced by Francesco Nicassio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Nicassio. The network helps show where Francesco Nicassio may publish in the future.
Co-authorship network of co-authors of Francesco Nicassio
This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Nicassio. A scholar is included among the top collaborators of Francesco Nicassio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Nicassio. Francesco Nicassio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 14 | |
| 3 | 9 | |
| 4 | 9 | |
| 5 | 123 | |
| 6 | 60 | |
| 7 | 53 | |
| 8 | 44 | |
| 9 | 65 | |
| 10 | 24 | |
| 11 | 39 | |
| 12 | 49 | |
| 13 | 35 | |
| 14 | 5 | |
| 15 | 44 | |
| 16 | 4 | |
| 17 | 73 | |
| 18 | 51 | |
| 19 | 14 | |
| 20 | 90 |
About Francesco Nicassio
Francesco Nicassio is a scholar working on Cancer Research, Molecular Biology and Developmental Neuroscience, having authored 47 papers that have together received 2.4k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (19 papers) and RNA modifications and cancer (12 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (1.9k citations) and Developmental Neuroscience (51 citations). Francesco Nicassio has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Pier Paolo Di Fiore, Matteo Jacopo Marzi, Fabrizio Bianchi, Elisabetta Citterio, Patrick Maisonneuve, Giulia Veronesi, Francesco Ghini, Joseph H.A. Vissers, Valentina Dall’Olio and Ian Marc Bonapace. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.